Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Structural Biology and Molecular Modeling Techniques
... the year 2023, is expected to reach US$33.0 Billion by 2030, growing at a CAGR of 16.7% over the analysis period 2023-2030. SaaS & Standalone Modeling Tool, one of the segments analyzed in the report, ... Read More
-
Orthopedic Bone Cement
... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$944.8 ... Read More
-
Recombinant DNA Technology
... by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Medical Recombinant DNA Technology, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$70.4 ... Read More
-
Research Antibodies
... at a CAGR of 4.9% over the analysis period 2023-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$4.8 Billion by the end of the ... Read More
-
Fucoxanthin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... million by 2030 with a CAGR of 4.77% during the forecast period 2024-2030. North American market for Fucoxanthin was valued at $ 13.54 million in 2023 and will reach $ 19.34 million by 2030, at ... Read More
-
Guillain-Barre Syndrome Therapeutics
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Intravenous Immunoglobulin Therapeutics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$541.2 Million ... Read More
-
Atomic Spectroscopy
... at a CAGR of 6.9% over the analysis period 2023-2030. Pharmaceuticals & Biotechnology Testing Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$6.2 Billion by ... Read More
-
In Vivo Contract Research Organization (CRO)
... the year 2023, is expected to reach US$7.1 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Smalll Molecules Modality, one of the segments analyzed in the report, is expected ... Read More
-
Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment
... is expected to reach US$8.4 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2023-2030. Medication Treatment, one of the segments analyzed in the report, is expected to record a 9.0% ... Read More
-
Food Enzymes
... at a CAGR of 6.0% over the analysis period 2023-2030. Microorganisms Source, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$3.6 Billion by the end of ... Read More
-
Metagenomic Sequencing
... at a CAGR of 17.6% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$4.3 Billion by the ... Read More
-
Plant Cell Culture Equipment
... reach US$2.6 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Centrifuges, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$784.8 ... Read More
-
Plant Biotechnology Equipment
... by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Breeding Application, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$25.6 Billion by ... Read More
-
Single Use Assemblies
... by 2030, growing at a CAGR of 20.2% over the analysis period 2023-2030. Bag Assemblies, one of the segments analyzed in the report, is expected to record a 23.9% CAGR and reach US$8.8 Billion by ... Read More
-
Biotherapeutics Cell Line Development
... reach US$150.7 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Transfection & Selection Process, one of the segments analyzed in the report, is expected to record a 7.9% CAGR ... Read More
-
Bone Marrow Aspirate Concentrates
... reach US$254.0 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Bone Marrow Aspirate Concentrates Systems, one of the segments analyzed in the report, is expected to record a 5.2% ... Read More
-
Synthetic Protein
... at a CAGR of 15.6% over the analysis period 2023-2030. The U.S. Market is Estimated at US$77.7 Million While China is Forecast to Grow at 20.1% CAGR The Synthetic Protein market in the U.S. is ... Read More
-
Fruit and Vegetable Processing Enzymes
... is expected to reach US$66.9 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Amylase, one of the segments analyzed in the report, is expected to record a 6.9% CAGR ... Read More
-
Molecular Breeding
... at a CAGR of 17.5% over the analysis period 2023-2030. Marker-Assisted Selection (MAS) Process, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$11.7 Billion by the ... Read More
-
Next Generation Sequencing (NGS) Sample Preparation
... the year 2023, is expected to reach US$10.5 Billion by 2030, growing at a CAGR of 18.1% over the analysis period 2023-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected ... Read More
-
Plant Breeding and CRISPR Plants
... is expected to reach US$50.1 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2023-2030. Conventional Breeding, one of the segments analyzed in the report, is expected to record a 11.6% ... Read More
-
Genomics and Proteomics Reagents, Research Kits and Analytical Instruments
... Kits and Analytical Instruments estimated at US$79.0 Billion in the year 2023, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Biochips & Microarrays, one ... Read More
-
Antisense and RNAi Therapeutics
... reach US$3.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Extracellular Matrix (ECM) Patches
... reach US$67.3 Million by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Porcine Raw Material, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and ... Read More
-
Biotech Business November 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
Research Assistance
